Skip to content

USANA Health Sciences USNA Derivative Liabilities - Fair Value

Derivative Liabilities - Fair Value at other companies

Liberty Global logo
Liberty GlobalLBTYB
$58.1M-18.5%
Dolby Laboratories, Inc. logo
Dolby Laboratories, Inc.DLB
$48K
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
$5.73M-70.2%
Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$301K0.0%
USANA Health Sciences logo
USANA Health SciencesUSNA
$344K
CrossAmerica Partners logo
CrossAmerica PartnersCAPL
$431K+191%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DerivativeLiabilities.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's derivative liabilities - fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's derivative liabilities - fair value?
USANA Health Sciences (USNA) reported derivative liabilities - fair value of $344K in Q1 2026.
What does derivative liabilities - fair value mean?
This metric represents the total fair market value of all derivative contracts currently in a liability position for the institution. It reflects the potential cash outflow required if these contracts were settled at the current reporting date. Monitoring this value is essential for assessing the bank's exposure to market volatility and counterparty risk.